WallStreetZenWallStreetZen

NASDAQ: NRSN
Neurosense Therapeutics Ltd Stock

$1.88+0.31 (+19.75%)
Updated Jun 2, 2023
NRSN Price
$1.88
Fair Value Price
N/A
Market Cap
$22.15M
52 Week Low
$1.08
52 Week High
$4.47
P/E
-1.62x
P/B
7.67x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$13.51M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.85
Operating Cash Flow
N/A
Beta
0.57
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NRSN Overview

NeuroSense Therapeutics Ltd. is developing treatment for patients with debilitating neurodegenerative diseases.The company's lead product, PrimeC, is a novel oral formulation in clinical trials to treat amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease, and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics was incorporated in 2017 and is headquartered in Herzliya, Israel.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NRSN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NRSN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NRSN is poor value based on its book value relative to its share price (7.67x), compared to the US Biotechnology industry average (5.2x)
P/B vs Industry Valuation
NRSN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NRSN due diligence checks available for Premium users.

Be the first to know about important NRSN news, forecast changes, insider trades & much more!

NRSN News

Valuation

NRSN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.62x
Industry
11.51x
Market
52.69x

NRSN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.67x
Industry
5.2x
NRSN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NRSN's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.9M
Profit Margin
0%

Assets to liabilities

Assets
$5.3M
Liabilities
$2.4M
Debt to equity
0.85
NRSN's short-term assets ($5.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NRSN's short-term assets ($5.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NRSN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A

NRSN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NRSN$22.15M+19.75%-1.62x7.67x
NTRB$22.09M+2.55%-5.32x2.58x
IKT$22.08M+0.71%-1.03x0.87x
ABVC$22.03M-0.75%-1.75x13.19x
ACER$21.72M+3.35%-0.50x-0.83x

Neurosense Therapeutics Stock FAQ

What is Neurosense Therapeutics's quote symbol?

(NASDAQ: NRSN) Neurosense Therapeutics trades on the NASDAQ under the ticker symbol NRSN. Neurosense Therapeutics stock quotes can also be displayed as NASDAQ: NRSN.

If you're new to stock investing, here's how to buy Neurosense Therapeutics stock.

What is the 52 week high and low for Neurosense Therapeutics (NASDAQ: NRSN)?

(NASDAQ: NRSN) Neurosense Therapeutics's 52-week high was $4.47, and its 52-week low was $1.08. It is currently -57.94% from its 52-week high and 74.88% from its 52-week low.

How much is Neurosense Therapeutics stock worth today?

(NASDAQ: NRSN) Neurosense Therapeutics currently has 11,781,963 outstanding shares. With Neurosense Therapeutics stock trading at $1.88 per share, the total value of Neurosense Therapeutics stock (market capitalization) is $22.15M.

Neurosense Therapeutics stock was originally listed at a price of $4.04 in Dec 9, 2021. If you had invested in Neurosense Therapeutics stock at $4.04, your return over the last 1 years would have been -53.47%, for an annualized return of -53.47% (not including any dividends or dividend reinvestments).

How much is Neurosense Therapeutics's stock price per share?

(NASDAQ: NRSN) Neurosense Therapeutics stock price per share is $1.88 today (as of Jun 2, 2023).

What is Neurosense Therapeutics's Market Cap?

(NASDAQ: NRSN) Neurosense Therapeutics's market cap is $22.15M, as of Jun 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Neurosense Therapeutics's market cap is calculated by multiplying NRSN's current stock price of $1.88 by NRSN's total outstanding shares of 11,781,963.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.